Literature DB >> 1313848

Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor.

M Gavish1, Y Katz, S Bar-Ami, R Weizman.   

Abstract

The PBR is a mitochondrial protein composed of at least two subunits, an approximately 30-kDa subunit that contains the site for BZs and an approximately 18-kDa subunit that binds isoquinoline carboxamide derivatives. Porphyrins and diazepam binding inhibitor are putative endogenous ligands for these receptors, which are under neural and hormonal control. Alterations in the density of PBR seem to be a sensitive indicator of stress: up-regulation after acute stress and down-regulation induced by repeated stress. PBR-specific ligands are involved in the control of cell proliferation and differentiation, and their binding is increased in some cancer tumors. Numerous studies in various endocrine organs have revealed that PBR are located in specific regions or tissues in the organs. Furthermore, PBR densities in various organs subject to hormonal control are regulated by organotropic hormones. At least in some cases, BZ ligands do not exert a specific effect in an organ, but rather modulate the well-documented effects of that particular hormone. To the best of our knowledge, BZ ligand action in peripheral tissues is dependent on recognition of PBR, which may suggest a receptor-mediated action.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313848     DOI: 10.1111/j.1471-4159.1992.tb10030.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

Review 1.  The peripheral benzodiazepine receptors: a review.

Authors:  A Beurdeley-Thomas; L Miccoli; S Oudard; B Dutrillaux; M F Poupon
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

Review 2.  Searching for neuropathology: gliosis in schizophrenia.

Authors:  Tatiana P Schnieder; Andrew J Dwork
Journal:  Biol Psychiatry       Date:  2010-10-30       Impact factor: 13.382

Review 3.  Acyl-CoA binding proteins: multiplicity and function.

Authors:  R E Gossett; A A Frolov; J B Roths; W D Behnke; A B Kier; F Schroeder
Journal:  Lipids       Date:  1996-09       Impact factor: 1.880

4.  Tissue-specific alterations of binding sites for peripheral-type benzodiazepine receptor ligand [3H]PK11195 in rats following portacaval anastomosis.

Authors:  V L Rao; R Audet; G Therrien; R F Butterworth
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

5.  Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism.

Authors:  M L Vargas; C Abella; J Hernandez
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors.

Authors:  F Kapczinski; H V Curran; R Przemioslo; R Williams; E Fluck; C Fernandes; S E File
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

7.  Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration.

Authors:  D G MacGregor; T W Stone
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

8.  Allosteric modulation by benzodiazepines of GABA-gated chloride channels of an identified insect motor neurone.

Authors:  Steven D Buckingham; Yoshiaki Higashino; David B Sattelle
Journal:  Invert Neurosci       Date:  2009-10-22

Review 9.  PET: brain tumor biochemistry.

Authors:  U Roelcke
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.

Authors:  G Olmos; A M Gabilondo; A Miralles; P V Escriba; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.